GLP-1 Market
LLY $1351.12 ▼ -2.3% NVO $38.87 ▼ -1.4% PFE $27.54 ▼ -1.9% VKTX $25.84 ▼ -1.3% KLRA $11.58 ▼ -1.8% GPCR $17.12 ▼ -1.4% RHHBY $58.99 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Tamoxifen Citrate

Company
National Cancer Institute (NCI)
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
46 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

46 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026

Find a Clinical Trial Near Me

See recruiting studies for Tamoxifen Citrate and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01788839

    Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

    Memorial Sloan Kettering Cancer Center 475 participants Est. completion 2027-02 7 sites
    Other conditions: Breast Cancer, Lymphoma, Hodgkin's Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04293796

    Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)

    Not yet reported N.N. Petrov National Medical Research Center of Oncology 60 participants Est. completion 2028-12-10 1 site Stand-alone
    Other conditions: Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
    View official trial listing →
  • Recruiting NCT NCT04312399

    Hormone Replacement Trial Against ALzheimers' Disease

    Not yet reported University Hospital, Ghent 600 participants Est. completion 2028-12-31 1 site
    Other conditions: Postmenopausal Symptoms, Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT04476485

    Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

    Shengjing Hospital 1000 participants Est. completion 2026-12-31 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04557449

    Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

    Not yet reported Pfizer 430 participants Est. completion 2029-10-07 39 sites Stand-alone
    Obstructive sleep apnea Other conditions: Prostate Cancer, Advanced Breast Cancer, NSCLC (Non-small Cell Lung Cancer), Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT04740697

    Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

    Not yet reported Institut Claudius Regaud 200 participants Est. completion 2028-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04765098

    Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

    Not yet reported AHS Cancer Control Alberta 60 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Recruiting NCT NCT04985266

    A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

    Not yet reported Royal Marsden NHS Foundation Trust 1100 participants Est. completion 2030-09-01 49 sites
    Other conditions: ER+ Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05056857

    Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

    M.D. Anderson Cancer Center 290 participants Est. completion 2026-10-31 1 site
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05306041

    Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer

    Not yet reported GBG Forschungs GmbH 170 participants Est. completion 2027-03 62 sites Stand-alone
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05467891

    Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

    Not yet reported Oana Danciu 200 participants Est. completion 2029-08-15 21 sites Stand-alone
    Other conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05512364

    Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 220 participants Est. completion 2035-11-01 113 sites
    Other conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05768139

    First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

    Not yet reported, Not yet reported Eli Lilly and Company 880 participants Est. completion 2030-07 65 sites Stand-alone
    Other conditions: Breast Cancer, Solid Tumors, Adult
    View official trial listing →
  • Recruiting NCT NCT05878314

    Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer

    University Hospital Tuebingen 504 participants Est. completion 2035-04 1 site
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05891093

    Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

    Not yet reported Fudan University 766 participants Est. completion 2031-05-31 15 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05941520

    Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

    Not yet reported National Cancer Institute (NCI) 80 participants Est. completion 2028-09-01 4 sites
    Other conditions: Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
    View official trial listing →
  • Recruiting NCT NCT05982093

    Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

    Not yet reported SOLTI Breast Cancer Research Group 96 participants Est. completion 2026-12 15 sites
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Premenopausal Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06075953

    DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

    Not yet reported QuantumLeap Healthcare Collaborative 400 participants Est. completion 2033-11 31 sites Stand-alone
    Other conditions: Ductal Carcinoma in Situ
    View official trial listing →
  • Recruiting NCT NCT06195306

    Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2028-01-01 3 sites Stand-alone
    Other conditions: Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
    View official trial listing →
  • Recruiting NCT NCT06218303

    Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

    Not yet reported Finn, Olivera, PhD 50 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Ductal Carcinoma in Situ
    View official trial listing →
  • Recruiting NCT NCT06320990

    Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

    Not yet reported University of Nebraska 15 participants Est. completion 2029-05 1 site Stand-alone
    Other conditions: Pancreatic Cyst, Pancreatic Mucinous Cystic Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06348134

    Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

    Not yet reported University of Chicago 74 participants Est. completion 2036-07-01 4 sites Stand-alone
    Other conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2-positive Breast Cancer, Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06361940

    Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

    Not yet reported Medical College of Wisconsin 185 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06369285

    A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

    Not yet reported Puma Biotechnology, Inc. 225 participants Est. completion 2029-06-30 53 sites Stand-alone
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06434064

    Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

    Not yet reported Roswell Park Cancer Institute 30 participants Est. completion 2028-11-30 1 site Stand-alone
    Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable Triple-Negative Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06507618

    Pre-Operative Window of ET to Inform RT Decisions (POWER II)

    Not yet reported University of Virginia 354 participants Est. completion 2034-03-01 6 sites Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Recruiting NCT NCT06548919

    Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer

    SciClone Pharmaceuticals 450 participants Est. completion 2027-12-31 1 site
    Other conditions: ESR1 Gene Mutation, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06590857

    Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

    Not yet reported, Not yet reported RayzeBio, Inc. 64 participants Est. completion 2033-11 32 sites Stand-alone
    Other conditions: Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer With Bone Involvement, Bone Metastases in Subjects With Advanced Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Hormone-Sensitive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06914674

    Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

    Not yet reported Fudan University 30 participants Est. completion 2028-02-28 1 site Stand-alone
    Other conditions: Pancreatic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06917313

    FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

    Not yet reported Yale University 92 participants Est. completion 2028-03 2 sites
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06942039

    Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

    Not yet reported C17 Council 15 participants Est. completion 2032-12-31 13 sites Stand-alone
    Other conditions: CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor, Medulloblastoma, Childhood, Medulloblastoma, Group 3, Medulloblastoma, Group 4, Pineoblastoma, Neuroblastoma, Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Abundant Neuropil and True Rosettes, Ependymoblastoma, Medulloepithelioma, CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Nos
    View official trial listing →
  • Recruiting NCT NCT06944145

    New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

    Not yet reported Beth Israel Deaconess Medical Center 242 participants Est. completion 2030-08-31 1 site
    Other conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms
    View official trial listing →
  • Recruiting NCT NCT06979596

    A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

    Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sites Stand-alone
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT07019363

    CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

    Not yet reported Fudan University 1903 participants Est. completion 2033-04-15 1 site
    Other conditions: Breast Cancer, Adjuvant Therapy
    View official trial listing →
  • Recruiting NCT NCT07071038

    Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

    Not yet reported Dartmouth-Hitchcock Medical Center 62 participants Est. completion 2027-08-05 1 site
    Other conditions: Breast Cancer, Adjuvant Treatment, Early Stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07190443

    Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)

    Not yet reported Japanese Foundation for Cancer Research 290 participants Est. completion 2035-02-06 1 site Stand-alone
    Other conditions: Breast Cancer, Locoregional Recurrence, Abemaciclib, Endocrine Therapy
    View official trial listing →
  • Recruiting NCT NCT07289035

    Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.

    Not yet reported Azienda Ospedaliera Universitaria Integrata Verona 35 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Cystic Fibrosis - Complete
    View official trial listing →
  • Recruiting NCT NCT07349069

    A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 5500 participants Est. completion 2034-01 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07470606

    Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

    Not yet reported The University of Texas Health Science Center at San Antonio 108 participants Est. completion 2031-07 1 site
    Other conditions: Brain Tumor
    View official trial listing →
  • Recruiting NCT NCT07483307

    A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 176 participants Est. completion 2030-03-13 7 sites Stand-alone
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma, ER+ Breast Cancer, Lobular Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07502820

    The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

    Not yet reported Karolinska Institutet 1100 participants Est. completion 2036-08 4 sites Stand-alone
    Other conditions: Breast Cancer, Adjuvant Drug Therapy
    View official trial listing →
  • Recruiting NCT NCT07581834

    Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

    Not yet reported Fujian Cancer Hospital 2000 participants Est. completion 2032-06-30 2 sites Stand-alone
    Other conditions: Breast Diseases, Breast Neoplasms, Dalpiciclib, Endocrine Breast Diseases, CDK4/6 Inhibitor, HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07671885

    Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)

    Not yet reported Tokyo Women's Medical University 950 participants Est. completion 2039-01-27 49 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07762885

    Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

    Not yet reported Fudan University 636 participants Est. completion 2036-06 1 site Stand-alone
    Other conditions: Ductal Carcinoma In Situ, DCIS
    View official trial listing →
  • Recruiting NCT NCT07829380

    The Cardiovascular-Cognitive Health Initiative

    Not yet reported National Heart Centre Singapore 5000 participants Est. completion 2030-12 4 sites
    Other conditions: Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT07895511

    A Study of Skipping Radiation Therapy in People With Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 136 participants Est. completion 2031-10-16 7 sites Stand-alone
    Other conditions: HER2-positive Breast Cancer, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00000529

    Tamoxifen Study

    Not yet reported NSABP Foundation Inc Est. completion 1995-11
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Hypertension, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00001378

    A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

    Not yet reported National Cancer Institute (NCI) 75 participants Est. completion 2000-11 1 site
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00001436

    A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

    Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2000-09 1 site
    Obstructive sleep apnea Other conditions: Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00001504

    A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients

    Not yet reported National Cancer Institute (NCI) 18 participants Est. completion 2002-01 1 site
    Other conditions: Breast Cancer, Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT00001848

    The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612 participants Est. completion 2006-01 1 site
    Other conditions: Endometriosis, Pelvic Pain
    View official trial listing →
  • Completed NCT NCT00002528

    Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 473 participants Est. completion 2010-08 21 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002529

    Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 452 participants Est. completion 2010-08 20 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002580

    Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

    Not yet reported Scottish Cancer Therapy Network 1000 participants 10 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002581

    Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer

    Not yet reported Scottish Cancer Therapy Network 1000 participants 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002582

    Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

    Not yet reported Institute of Cancer Research, United Kingdom 6000 participants Est. completion 2007-04 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002595

    Toremifene in Treating Patients With Desmoid Tumors

    Not yet reported Advocate Lutheran General Hospital 72 participants Est. completion 2010-09 1 site
    Other conditions: Desmoid Tumor
    View official trial listing →
  • Completed NCT NCT00002608

    Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

    Not yet reported Ottawa Regional Cancer Centre 30 participants Est. completion 2005-04 1 site
    Other conditions: Adrenocortical Carcinoma, Brain and Central Nervous System Tumors, Head and Neck Cancer, Liver Cancer, Malignant Mesothelioma, Pheochromocytoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00002644

    Tamoxifen for the Prevention of Breast Cancer in High-Risk Women

    Not yet reported Queen Mary University of London 7154 participants Est. completion 2011-03-30 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002679

    Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

    Not yet reported Yale University 89 participants Est. completion 2002-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002720

    Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

    Not yet reported European Institute of Oncology 642 participants Est. completion 2012-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002777

    Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 342 participants 48 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002784

    High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 344 participants Est. completion 2011-12 11 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002864

    Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

    Not yet reported NCIC Clinical Trials Group 667 participants Est. completion 2010-04-23 40 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002920

    S9630, Medroxyprogesterone in Treating Women With Breast Cancer

    Not yet reported SWOG Cancer Research Network 313 participants Est. completion 2009-12 122 sites Stand-alone
    Other conditions: Breast Cancer, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00002967

    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

    Not yet reported NSABP Foundation Inc Est. completion 2006-03 108 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003016

    Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

    Not yet reported University of Oxford 20000 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003032

    High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

    Not yet reported NCIC Clinical Trials Group 224 participants Est. completion 2008-12-15 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003035

    Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

    Not yet reported Georgetown University 40 participants Est. completion 2001-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003050

    Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

    Not yet reported University of Southern California 46 participants Est. completion 2000-03 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003080

    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-05 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00003099

    Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 52 participants Est. completion 2003-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003140

    Letrozole After Tamoxifen in Treating Women With Breast Cancer

    Not yet reported NCIC Clinical Trials Group 5187 participants Est. completion 2003-10 57 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003199

    Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003418

    Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

    Not yet reported International Collaborative Cancer Group 4400 participants 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003678

    Tamoxifen in Treating Women With Breast Cancer

    Not yet reported University Hospital Birmingham 20000 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003679

    Combination Chemotherapy in Treating Women With Breast Cancer

    Not yet reported Scottish Cancer Therapy Network 350 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003680

    Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

    Not yet reported Scottish Cancer Therapy Network 300 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003857

    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

    Not yet reported Radiation Therapy Oncology Group 636 participants Est. completion 2022-05-20 369 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00003865

    Toremifene in Treating Patients With Ovarian Cancer

    Not yet reported George Washington University Est. completion 2017-02-22 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00003953

    Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

    Not yet reported Case Comprehensive Cancer Center 39 participants Est. completion 2013-01 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003972

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 280 participants Est. completion 2003-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004125

    Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

    Not yet reported Eastern Cooperative Oncology Group Est. completion 2016-11 48 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004205

    Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 8028 participants Est. completion 2016-06-30 3 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004915

    Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

    Not yet reported Northwestern University Est. completion 2000-02 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00005605

    Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

    Northwestern University 79 participants Est. completion 2005-10 1 site
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00005822

    SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

    Not yet reported Case Comprehensive Cancer Center 21 participants Est. completion 2003-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00005886

    Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

    Not yet reported University of Kansas Medical Center Est. completion 2002-08 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00005908

    Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

    Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Breast Cancer, Breast Neoplasm
    View official trial listing →
  • Status unknown NCT NCT00006030

    Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer

    Not yet reported British Association of Surgical Oncology: Breast Group 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00006369

    ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00007904

    Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

    Not yet reported Case Comprehensive Cancer Center 16 participants Est. completion 2012-09 3 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00009997

    Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

    Not yet reported NYU Langone Health 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00010322

    Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported Intarcia Therapeutics Est. completion 2001-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00014638

    Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

    Not yet reported Novartis Est. completion 2002-03 20 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00016276

    Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) 396 participants 1 site Stand-alone
    Other conditions: Cardiac Toxicity, Inflammatory Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00016341

    Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

    Not yet reported Gynecologic Oncology Group 50 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00016432

    Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

    Not yet reported NSABP Foundation Inc 1598 participants Est. completion 2011-02 162 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00019500

    Raloxifene in Preventing Breast Cancer in Premenopausal Women

    Not yet reported National Cancer Institute (NCI) Est. completion 2005-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00024336

    Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma

    Not yet reported Children's Cancer and Leukaemia Group 22 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00026286

    Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

    Not yet reported Eastern Cooperative Oncology Group Est. completion 2007-06-15 24 sites
    Other conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00026585

    Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder

    Not yet reported National Institute of Mental Health (NIMH) 50 participants Est. completion 2007-11-02 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00028353

    A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)

    Not yet reported GTx 500 participants Est. completion 2003-07 25 sites
    Other conditions: Prostatic Intraepithelial Neoplasia
    View official trial listing →
  • Completed NCT NCT00030147

    Raloxifene and Rimostil for Perimenopause-Related Depression

    Not yet reported National Institute of Mental Health (NIMH) 65 participants Est. completion 2015-06 1 site
    Other conditions: Perimenopausal Depression, Depression
    View official trial listing →
  • Completed NCT NCT00031720

    Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

    Not yet reported Alliance for Clinical Trials in Oncology 112 participants Est. completion 2013-11 14 sites Stand-alone
    Other conditions: Breast Cancer, Hot Flashes, Hot Flushes
    View official trial listing →
  • Completed NCT NCT00031811

    Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer

    Not yet reported OHSU Knight Cancer Institute 80 participants Est. completion 2003-04 1 site
    Other conditions: Breast Cancer, Menopausal Symptoms, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00031850

    Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

    Not yet reported Institute of Cancer Research, United Kingdom 150 participants Est. completion 2007-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00032136

    Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

    Not yet reported Cancer Research Campaign Clinical Trials Centre 4400 participants Est. completion 2009-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00033683

    Combination Chemotherapy in Treating Women With Resected Breast Cancer

    Not yet reported Institute of Cancer Research, United Kingdom 69 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00035256

    Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis

    Not yet reported Eli Lilly and Company 330 participants Est. completion 2005-07 5 sites
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00038103

    Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

    Not yet reported Pfizer 111 participants Est. completion 2008-03 20 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00038467

    Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer

    Not yet reported Pfizer 4740 participants Est. completion 2013-03 377 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00041080

    Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

    Not yet reported National Cancer Institute (NCI) 139 participants Est. completion 2011-01 1 site Stand-alone
    Other conditions: Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    View official trial listing →
  • Completed NCT NCT00046137

    Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

    Not yet reported Eli Lilly and Company 13 sites
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00047099

    Combination Chemotherapy in Treating Women With Breast Cancer

    Not yet reported Ludwig-Maximilians - University of Munich 446 participants Est. completion 2012-03 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00052728

    Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) Est. completion 2006-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00053339

    Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology Stand-alone
    Other conditions: Stage IV Breast Cancer, Recurrent Breast Cancer
    View official trial listing →
  • Completed NCT NCT00053898

    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

    Not yet reported NSABP Foundation Inc 3104 participants Est. completion 2016-05 740 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00065767

    Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

    Not yet reported, Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2005-03 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00066690

    Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 3066 participants Est. completion 2024-11-06 500 sites Stand-alone
    Other conditions: Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00066807

    Premenopausal Endocrine Responsive Chemotherapy Trial

    Not yet reported ETOP IBCSG Partners Foundation 29 participants Est. completion 2006-12 6 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00072462

    Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

    Not yet reported Queen Mary University of London 2980 participants Est. completion 2021-05-31 97 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00083044

    Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

    Northwestern University Est. completion 2008-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00086749

    Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer

    Northwestern University 53 participants Est. completion 2007-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00096369

    Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

    Not yet reported University of Texas Southwestern Medical Center 130 participants Est. completion 2007-03-15 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00097344

    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 842 participants Est. completion 2006-08 104 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent
    View official trial listing →
  • Completed NCT NCT00106691

    Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

    Not yet reported GTx 1589 participants Est. completion 2010-02 138 sites
    Other conditions: Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia
    View official trial listing →
  • Completed NCT NCT00107263

    Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 558 participants Est. completion 2012-08
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00108069

    Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

    Not yet reported National Cancer Institute (NCI) 43 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Glioma
    View official trial listing →
  • Completed NCT NCT00118157

    Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

    Not yet reported National Cancer Institute (NCI) 19 participants Est. completion 2014-09 2 sites Stand-alone
    Other conditions: Estrogen Receptor Positive, Male Breast Carcinoma, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00119262

    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 226 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00126464

    Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

    Not yet reported Cedars-Sinai Medical Center 100 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00149604

    AFTER: Altering Fat Through Estrogen and Raloxifene

    Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2006-02 1 site
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00152178

    The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

    Not yet reported Taiho Pharmaceutical Co., Ltd. 680 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00163137

    Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

    Not yet reported Ligand Pharmaceuticals 540 participants Est. completion 2005-10 72 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00165308

    Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

    Not yet reported Dana-Farber Cancer Institute 29 participants Est. completion 2009-06 2 sites Stand-alone
    Other conditions: Hodgkin's Disease, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00174707

    Study of Docetaxel in Breast Cancer Patients

    Not yet reported Sanofi 998 participants Est. completion 2007-12 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT00183963

    A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

    Not yet reported University of Southern California 4 participants Est. completion 2008-06 1 site
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT00189358

    A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

    Not yet reported AGO Study Group 1 site
    Other conditions: Ovarian Cancer, Cancer of the Fallopian Tube, Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT00190593

    Raloxifene Use for The Heart

    Not yet reported Eli Lilly and Company 10000 participants Est. completion 2005-11 1 site
    Cardiovascular disease Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00191425

    2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis

    Not yet reported Eli Lilly and Company 810 participants Est. completion 2005-11 1 site
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Completed NCT NCT00201851

    Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

    Not yet reported International Breast Cancer Research Foundation 740 participants Est. completion 2013-05 9 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00206466

    Biologic Correlative Taxotere/AC

    Not yet reported Baylor Breast Care Center 70 participants Est. completion 2012-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00206492

    Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

    Not yet reported Baylor Breast Care Center 3 participants Est. completion 2006-10 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00210028

    Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

    Not yet reported Institut Claudius Regaud 40 participants Est. completion 2008-08 3 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00214110

    Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]

    Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2005-01 1 site
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
  • Completed NCT NCT00228930

    Tamoxifen Pharmacogenetics and Clinical Effects

    National Institute of General Medical Sciences (NIGMS) 297 participants Est. completion 2007-08 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00229697

    Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

    Not yet reported AstraZeneca 317 participants Est. completion 2015-06 55 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00232661

    PROACT - Pre-Operative Arimidex Compared To Tamoxifen

    Not yet reported AstraZeneca 452 participants Est. completion 2007-12 79 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00233610

    Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

    Not yet reported AstraZeneca 180 participants Est. completion 2007-10 11 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00240071

    Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

    Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00241449

    A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

    Not yet reported AstraZeneca 51 participants Est. completion 2012-01 139 sites
    Other conditions: Breast Cancer, Metastasis
    View official trial listing →
  • Completed NCT NCT00246961

    Arimidex Observational: Reason for and Effect of Change From Tamoxifen

    AstraZeneca 200 participants 33 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00253539

    Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

    Not yet reported The Cleveland Clinic 3 participants Est. completion 2005-04 Stand-alone
    Other conditions: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2)
    View official trial listing →
  • Completed NCT NCT00272714

    Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women

    Not yet reported ASCEND Therapeutics 146 participants Est. completion 2005-04
    Other conditions: Cyclic Breast Pain, Cyclic Mastalgia
    View official trial listing →
  • Completed NCT NCT00279448

    Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer

    Not yet reported Pfizer 9779 participants Est. completion 2009-06 59 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00287534

    Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

    Not yet reported AstraZeneca 1059 participants Est. completion 2004-09 43 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00290654

    Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

    Not yet reported Masonic Cancer Center, University of Minnesota 45 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00290745

    Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

    Not yet reported, Not yet reported University of California, San Francisco 79 participants Est. completion 2011-06-30 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00293540

    Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

    Not yet reported International Breast Cancer Research Foundation 249 participants Est. completion 2015-03 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00295100

    Tamoxifen-MRI Study

    Not yet reported University of Pennsylvania 78 participants Est. completion 2006-07 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00301457

    Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

    Not yet reported Maastricht University Medical Center 1914 participants Est. completion 2022-04 67 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00305838

    CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

    Not yet reported Mount Vernon Cancer Centre at Mount Vernon Hospital 200 participants 24 sites
    Other conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00309491

    Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

    Not yet reported Austrian Breast & Colorectal Cancer Study Group 2021 participants Est. completion 2000-03 Stand-alone
    Other conditions: Early-stage Breast Cancer
    View official trial listing →
  • Completed NCT NCT00332553

    Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

    Not yet reported Eli Lilly and Company 150 participants Est. completion 2004-05 1 site
    Other conditions: Vasomotor Symptoms, Endometrial Safety
    View official trial listing →
  • Completed NCT NCT00343616

    Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98

    Not yet reported ETOP IBCSG Partners Foundation 135 participants Est. completion 2009-05 12 sites Stand-alone
    Other conditions: Breast Cancer, Cognitive/Functional Effects, Fatigue, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Completed NCT NCT00349011

    Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer

    Not yet reported Yale University 60 participants Est. completion 2004-03 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT00361543

    Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

    Not yet reported The Alfred 54 participants Est. completion 2014-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00365599

    Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 43 participants Est. completion 2012-08 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00367081

    Treatment of Cerebral Toxoplasmosis in HIV/AIDS

    Not yet reported Department of Medical Services Ministry of Public Health of Thailand 30 participants Est. completion 2004-08 1 site
    Other conditions: Toxoplasmic Encephalitis, AIDS
    View official trial listing →
  • Completed NCT NCT00368459

    Raloxifene for Women With Alzheimer's Disease

    Not yet reported Stanford University 42 participants Est. completion 2012-01 4 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00369850

    Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

    Not yet reported ETOP IBCSG Partners Foundation 458 participants Est. completion 2012-01 16 sites Stand-alone
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00371956

    Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

    Not yet reported Tuen Mun Hospital 114 participants Est. completion 2010-02 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00375622

    Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

    Not yet reported Rabin Medical Center 60 participants Est. completion 2006-06 1 site
    Other conditions: Hereditary Hemorrhagic Telangiectasia
    View official trial listing →
  • Completed NCT NCT00381927

    Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer Development

    Baystate Medical Center 80 participants Est. completion 2006-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00383422

    Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

    Not yet reported Eli Lilly and Company 320 participants Est. completion 2008-07 21 sites
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Status unknown NCT NCT00398489

    Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

    Not yet reported Technical University of Munich 94 participants 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00412022

    HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.

    Not yet reported National Cancer Institute, Naples 1294 participants Est. completion 2024-11 20 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00424164

    Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 20 participants Est. completion 2010-05-28 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00427700

    Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome

    Not yet reported Hospital de Clinicas de Porto Alegre 82 participants Est. completion 2009-08 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT00437359

    Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

    Not yet reported Japan Breast Cancer Research Network 240 participants Est. completion 2020-05 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00440349

    Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis

    Not yet reported University of Parma 38 participants Est. completion 2007-04 1 site
    Other conditions: Retroperitoneal Fibrosis
    View official trial listing →
  • Status unknown NCT NCT00449514

    Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle

    Not yet reported Shaare Zedek Medical Center 100 participants 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00482391

    Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 95 participants Est. completion 2011-07 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00489944

    Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

    Not yet reported San Diego Pacific Oncology & Hematology Associates 50 participants 1 site
    Other conditions: Intraocular Melanoma
    View official trial listing →
  • Status unknown NCT NCT00492505

    Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

    Not yet reported San Diego Pacific Oncology & Hematology Associates 200 participants 1 site
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00532246

    Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

    Not yet reported Eli Lilly and Company 147 participants Est. completion 2003-08 5 sites
    Other conditions: Osteoporosis, Post-Menopausal
    View official trial listing →
  • Completed NCT NCT00532428

    Long Term Effects of Raloxifene Treatment on Bone Quality

    Not yet reported Eli Lilly and Company 31 participants Est. completion 2003-09 7 sites
    Other conditions: Osteoporosis, Post-Menopausal
    View official trial listing →
  • Status unknown NCT NCT00541086

    Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

    Not yet reported Gruppo Italiano Mammella (GIM) 3697 participants Est. completion 2020-07 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00541138

    Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

    Not yet reported City of Hope Medical Center 50 participants Est. completion 2007-10 1 site
    Other conditions: Brain and Central Nervous System Tumors, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00543829

    German Preoperative Adriamycin Docetaxel Study

    Not yet reported GBG Forschungs GmbH 250 participants Est. completion 1999-06 Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00569543

    Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

    University of Nebraska 27 participants Est. completion 2012-08-02 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00590785

    Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2015-01-13 1 site Stand-alone
    Other conditions: High Risk, Breast Cancer, Positive Nodes, Cyclophosphamide, Doxorubicin
    View official trial listing →
  • Completed NCT NCT00605267

    Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

    Not yet reported AstraZeneca 197 participants Est. completion 2010-12 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00637871

    Casodex - Nolvadex Combination

    Not yet reported AstraZeneca Est. completion 2005-08
    Other conditions: Gynaecomastia, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00649090

    A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

    Not yet reported Pfizer 1549 participants Est. completion 2007-04 61 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00659373

    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

    Not yet reported ETOP IBCSG Partners Foundation 86 participants Est. completion 2016-04 15 sites Stand-alone
    Other conditions: Breast Cancer, Fatigue, Sleep Disorders
    View official trial listing →
  • Completed NCT NCT00667121

    Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

    Mayo Clinic 88 participants Est. completion 2014-05-27 6 sites
    Other conditions: Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
    View official trial listing →
  • Completed NCT NCT00670319

    Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

    Not yet reported Eli Lilly and Company 7705 participants Est. completion 1999-09 25 sites
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Terminated NCT NCT00684216

    Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

    Not yet reported, Not yet reported The Netherlands Cancer Institute 10 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00717015

    Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer

    National University Hospital, Singapore 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00727883

    Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

    AstraZeneca 190 participants Est. completion 2008-05
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00729586

    Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

    Not yet reported National Cancer Institute (NCI) 73 participants Est. completion 2017-02 108 sites Stand-alone
    Other conditions: Endometrial Carcinoma, Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Uterine Corpus Cancer, Stage IIIC1 Uterine Corpus Cancer, Stage IIIC2 Uterine Corpus Cancer, Stage IVA Uterine Corpus Cancer, Stage IVB Uterine Corpus Cancer
    View official trial listing →
  • Suspended NCT NCT00738777

    Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

    Not yet reported The Netherlands Cancer Institute 250 participants Est. completion 2024-06 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00749138

    Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

    Not yet reported Bader, Ted, M.D. 18 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00754845

    Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy

    Not yet reported Canadian Cancer Trials Group 1918 participants Est. completion 2017-04-19 43 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00756717

    Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer

    Not yet reported Loyola University 22 participants Est. completion 2011-12-21 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00761332

    Back Pain in Patients With Severe Osteoporosis

    Eli Lilly and Company 650 participants Est. completion 2010-12 15 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00764322

    Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

    Not yet reported UNC Lineberger Comprehensive Cancer Center 501 participants Est. completion 2011-07-01 7 sites Stand-alone
    Other conditions: Breast Cancer, Menopausal Symptoms
    View official trial listing →
  • Completed NCT NCT00767585

    An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

    AstraZeneca 560 participants Est. completion 2009-06 1 site
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00774267

    Study Evaluating Changes In Mammographic Breast Density

    Pfizer 507 participants Est. completion 2010-04 26 sites
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00784680

    ATAC - Quality of Life Sub-Protocol

    Not yet reported AstraZeneca 308 participants Est. completion 2004-04
    Other conditions: Quality of Life
    View official trial listing →
  • Completed NCT NCT00784862

    ATAC - Pharmacokinetics (PK) Sub-Protocol

    Not yet reported AstraZeneca 9358 participants Est. completion 1999-03
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00784888

    Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

    Pfizer 344 participants Est. completion 2011-12 16 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00784940

    ATAC - Bone Density Sub-Protocol

    Not yet reported AstraZeneca 308 participants Est. completion 2007-04
    Other conditions: Bone Density
    View official trial listing →
  • Terminated NCT NCT00790101

    Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

    Not yet reported Sanofi 6 participants Est. completion 2004-10 1 site
    Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Terminated NCT NCT00810706

    Adjuvant Post-Tamoxifen Exemestane Trial

    Not yet reported Hellenic Breast Surgeons Society 448 participants Est. completion 2005-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00814034

    Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

    Hellenic Breast Surgeons Society 306 participants Est. completion 2011-12 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00814125

    ATAC - Endometrial Sub-Protocol

    Not yet reported AstraZeneca 285 participants Est. completion 2005-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00815555

    CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients

    Assaf-Harofeh Medical Center 500 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00827307

    Zoladex Plus Tamoxifen in Breast Cancer

    Not yet reported Zhejiang Cancer Hospital 100 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Mammography, Estrogen, Lipemia, Endometrium, Ultrasonography
    View official trial listing →
  • Completed NCT NCT00847366

    Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

    Not yet reported AEterna Zentaris 10 participants Est. completion 2012-12 Stand-alone
    Other conditions: Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, Sarcomas
    View official trial listing →
  • Terminated NCT NCT00847821

    Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

    Wyeth is now a wholly owned subsidiary of Pfizer 185 participants Est. completion 2010-08 22 sites
    Other conditions: Postmenopause
    View official trial listing →
  • Completed NCT NCT00849030

    ATAC - Arimidex, Tamoxifen Alone or in Combination

    Not yet reported AstraZeneca 9358 participants Est. completion 2010-04
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00873366

    Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

    Mayo Clinic 92 participants Est. completion 2015-09-23 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00884143

    Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer

    AstraZeneca 515 participants Est. completion 2010-01 3 sites
    Other conditions: Post Menopausal, Breast Cancer
    View official trial listing →
  • Completed NCT NCT00886535

    Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

    Milton S. Hershey Medical Center 41 participants Est. completion 2017-07-27 1 site
    Other conditions: Breast Cancer, Ductal Carcinoma in Situ
    View official trial listing →
  • Status unknown NCT NCT00896155

    Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients

    Not yet reported Tata Memorial Hospital 260 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Pulmonary Fibrosis, Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00897065

    Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

    Massachusetts General Hospital 957 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00897091

    S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

    SWOG Cancer Research Network 750 participants Est. completion 2007-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00899197

    Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer

    Wake Forest University Health Sciences 2 participants Est. completion 2012-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00899288

    Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98

    Not yet reported ETOP IBCSG Partners Foundation 60 participants Est. completion 2007-07 Stand-alone
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00900744

    A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6

    Icahn School of Medicine at Mount Sinai 121 participants Est. completion 2012-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00903162

    Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 17 participants Est. completion 2014-09 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00912548

    Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women

    Not yet reported Korean Breast Cancer Study Group 1234 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00929591

    SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

    Not yet reported SWOG Cancer Research Network 1558 participants Est. completion 2010-03 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00943527

    Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

    Mayo Clinic 110 participants Est. completion 2012-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00949598

    Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

    Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 177 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00963209

    Tamoxifen Citrate in Patients With Breast Cancer

    Not yet reported Centre Hospitalier Universitaire Vaudois 140 participants Est. completion 2013-12 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00963417

    Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

    Not yet reported ETOP IBCSG Partners Foundation 119 participants Est. completion 2024-10-23 13 sites
    Other conditions: Breast Cancer, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00965939

    An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients

    Vlaamse Vereniging voor Obstetrie en Gynaecologie 300 participants 12 sites
    Other conditions: ER-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT00966043

    Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes

    Vlaamse Vereniging voor Obstetrie en Gynaecologie 158 participants Est. completion 2011-07 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00967824

    Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 1683 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00973037

    CYP2D6 Genotype on the Clinical Effect of Tamoxifen

    Korea University Anam Hospital 922 participants Est. completion 2016-04 1 site
    Other conditions: Breast Neoplasms, Tamoxifen, Genotype, CYP2D6
    View official trial listing →
  • Completed NCT NCT00975676

    Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

    Not yet reported ETOP IBCSG Partners Foundation 123 participants Est. completion 2016-12 24 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00993642

    ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

    Not yet reported Tulane University Health Sciences Center Est. completion 2010-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00999921

    Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

    Not yet reported Medical College and Hospital Kolkata 256 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Benign Breast Disease, Fibrocystic Disease of Breast, Fibroadenoma, Mastalgia
    View official trial listing →
  • Completed NCT NCT01016665

    Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

    Not yet reported Federal University of São Paulo 71 participants Est. completion 2008-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01027416

    Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

    Not yet reported Roswell Park Cancer Institute 59 participants Est. completion 2015-12 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01041092

    Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women

    Not yet reported Fundació Sant Joan de Déu 34 participants Est. completion 2009-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01047358

    Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

    Pfizer 206 participants Est. completion 2014-06 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01050634

    Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

    Pfizer 980 participants Est. completion 2009-04
    Other conditions: Post Menopausal Women With Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT01073865

    Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

    Not yet reported AstraZeneca 222 participants Est. completion 2017-11-20 55 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01075802

    Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms

    Not yet reported Western Sydney Local Health District 121 participants Est. completion 2012-12 2 sites Stand-alone
    Other conditions: Breast Cancer, CYP2D6 Polymorphism
    View official trial listing →
  • Completed NCT NCT01077817

    Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

    Organon and Co 684815 participants Est. completion 2012-02-16
    Other conditions: Esophageal Cancer, Squamous Cell Carcinoma, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01124695

    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

    Not yet reported ECOG-ACRIN Cancer Research Group 124 participants Est. completion 2022-12 294 sites Stand-alone
    Other conditions: Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01157026

    A Pilot Clinical Trial With Tocotrienol on Breast Cancer

    Not yet reported Malaysia Palm Oil Board 240 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01166958

    Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?

    Not yet reported University of Wisconsin, Madison 26 participants Est. completion 2012-11 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01189500

    Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects

    Not yet reported Pfizer 30 participants Est. completion 2010-10 2 sites Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT01192308

    PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)

    Not yet reported Radboud University Medical Center 42 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01194427

    A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01231659

    Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 72 participants Est. completion 2017-04-30 7 sites
    Other conditions: Postmenopausal Women, Locally Advanced Metastatic Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01234532

    Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery

    Not yet reported University of Maryland, Baltimore 5 participants Est. completion 2017-05 1 site
    Other conditions: Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01239745

    Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

    Pfizer 46 participants Est. completion 2011-10 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01257581

    Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

    Not yet reported Nazem Atassi 60 participants Est. completion 2013-02 9 sites Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Status unknown NCT NCT01266213

    Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

    Not yet reported Samsung Medical Center 147 participants Est. completion 2019-12 1 site
    Other conditions: Metastatic Breast Cancer, Estrogen Receptor Positive Tumor, Breast Cancer Nos Premenopausal
    View official trial listing →
  • Active, not recruiting NCT NCT01272037

    Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

    Not yet reported National Cancer Institute (NCI) 5018 participants Est. completion 2027-01-08 1568 sites Stand-alone
    Other conditions: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Synchronous Bilateral Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT01272570

    Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors

    University of Michigan 58 participants Est. completion 2013-08 1 site
    Other conditions: Breast Cancer, Xerostomia
    View official trial listing →
  • Completed NCT NCT01273168

    Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

    Not yet reported National Cancer Institute (NCI) 40 participants Est. completion 2025-12-19 1 site Stand-alone
    Other conditions: Hormone Receptor-Positive Breast, Gynecologic, Desmoid, Hormone Receptor-Positive Neoplasms
    View official trial listing →
  • Completed NCT NCT01293032

    Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

    Not yet reported Virginia Commonwealth University 59 participants Est. completion 2016-03 8 sites Stand-alone
    Other conditions: Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01297231

    Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI

    Memorial Sloan Kettering Cancer Center Est. completion 2014-02
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01298713

    Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

    Not yet reported ARCAGY/ GINECO GROUP 111 participants Est. completion 2018-09-12 1 site Stand-alone
    Other conditions: Breast Neoplasms, mTor Protein
    View official trial listing →
  • Completed NCT NCT01334996

    Use of Tamoxifen in Systemic Mastocytosis

    Mayo Clinic 1 participants Est. completion 2019-08-28 1 site
    Other conditions: Systemic Mastocytosis
    View official trial listing →
  • Completed NCT NCT01341171

    The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

    University of Vermont 30 participants Est. completion 2018-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01352091

    Adjuvant AI Combined With Zoladex

    Not yet reported Fudan University 670 participants Est. completion 2018-04 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01357772

    Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

    Not yet reported Andrea DeCensi 500 participants Est. completion 2028-12-31 14 sites Stand-alone
    Other conditions: Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm, Breast Neoplasms, Atypical Hyperplasia
    View official trial listing →
  • Completed NCT NCT01384526

    Investigating the Impact of Tamoxifen Therapy on Ovarian Aging

    University of California, San Francisco 266 participants Est. completion 2015-03 1 site
    Other conditions: Breast Cancer, Fertility
    View official trial listing →
  • Completed NCT NCT01393990

    A Study of LY2228820 in Participants With Advanced Cancer

    Not yet reported Eli Lilly and Company 89 participants Est. completion 2013-12-14 2 sites Stand-alone
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01419197

    A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

    Not yet reported Hoffmann-La Roche 602 participants Est. completion 2015-08 184 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01503905

    Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2021-12 17 sites
    Other conditions: Breast Cancer Nos Premenopausal
    View official trial listing →
  • Completed NCT NCT01535027

    Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

    Not yet reported Medical University of Vienna 125 participants Est. completion 2012-12 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT01563211

    Predictive Model of Therapy Outcomes in Breast Cancer Patients

    Imperial College London 70 participants Est. completion 2014-08 1 site
    Other conditions: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
    View official trial listing →
  • Completed NCT NCT01564056

    Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

    Not yet reported UNICANCER 1989 participants Est. completion 2026-04 84 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01573637

    Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

    Not yet reported Fundació Sant Joan de Déu 78 participants Est. completion 2014-07 3 sites
    Other conditions: Schizophrenia in Post Menopausal Women
    View official trial listing →
  • Status unknown NCT NCT01579734

    Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users

    Not yet reported European Institute of Oncology 1884 participants Est. completion 2023-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01612728

    Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer

    Not yet reported Baylor Breast Care Center Est. completion 2014-10
    Other conditions: Breast Cancer, Arthralgia, Joint Pain
    View official trial listing →
  • Completed NCT NCT01612871

    Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer

    Not yet reported Institut Claudius Regaud 39 participants Est. completion 2016-01-28 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01614210

    Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance

    Not yet reported University of Utah 52 participants Est. completion 2016-11 1 site Stand-alone
    Other conditions: Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01622361

    Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

    Not yet reported Asan Medical Center 290 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01638247

    Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients

    Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2018-05 1 site Stand-alone
    Other conditions: Male Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01685255

    A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

    Not yet reported Incyte Corporation 83 participants Est. completion 2014-10-23 49 sites
    Other conditions: Ovarian Cancer, Genitourinary (GU) Tumors
    View official trial listing →
  • Completed NCT NCT01702610

    Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 50 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Glioblastoma Mutliforme
    View official trial listing →
  • Completed NCT NCT01712893

    Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer

    Not yet reported Fudan University 216 participants Est. completion 2017-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01745289

    Long-term Anastrozole Versus Tamoxifen Treatment Effects

    Queen Mary University of London 2671 participants Est. completion 2017-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01758146

    Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 412 participants Est. completion 2020-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01821066

    A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers

    Not yet reported Pfizer 25 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01937052

    Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 329 participants Est. completion 2024-11-25 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01950182

    Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer

    Not yet reported Sun Yat-sen University 392 participants Est. completion 2020-05-31 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01971515

    First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

    Not yet reported EMD Serono 101 participants Est. completion 2018-08-09 15 sites Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT02040857

    Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 162 participants Est. completion 2024-12-27 10 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02057133

    A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

    Not yet reported Eli Lilly and Company 198 participants Est. completion 2026-12 13 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02058381

    A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2018-06-19 15 sites Stand-alone
    Other conditions: Pre-menopausal Breast Cancer, PI3K Pathway Inhibition
    View official trial listing →
  • Terminated NCT NCT02089386

    Tamoxifen to Treat Barrett's Metaplasia

    Not yet reported Washington University School of Medicine 7 participants Est. completion 2016-06-21 1 site Stand-alone
    Other conditions: Barrett Metaplasia
    View official trial listing →
  • Status unknown NCT NCT02089854

    Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

    Not yet reported Peking Union Medical College Hospital 800 participants 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02094495

    Pilot Study About Tamoxifen Therapy for Breast Cancer Patients

    National Cancer Center, Korea 300 participants Est. completion 2017-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02097459

    Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

    Not yet reported Peking Union Medical College Hospital 600 participants 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02101788

    Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 260 participants Est. completion 2025-10-27 501 sites
    Other conditions: Borderline Ovarian Serous Tumor, Micropapillary Serous Carcinoma, Ovarian Serous Adenocarcinoma, Primary Peritoneal Serous Adenocarcinoma, Recurrent Ovarian Low Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Serous Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT02132000

    Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

    Not yet reported, Not yet reported Fengxi Su 3036 participants Est. completion 2020-05 1 site Stand-alone
    Other conditions: Breast Cancer Patients in Premenopausal, Estrogen and/or Progesterone Receptor Positive
    View official trial listing →
  • Status unknown NCT NCT02132390

    Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

    Not yet reported Peking Union Medical College Hospital 300 participants 1 site
    Other conditions: Breast Cancer, Chemotherapy Induced Amenorrhea, Ovarian Function Suppression
    View official trial listing →
  • Completed NCT NCT02166944

    Tamoxifen Treatment in Patients With Motor Neuron Disease

    Not yet reported, Not yet reported Taipei Medical University Shuang Ho Hospital 20 participants Est. completion 2019-09-18 1 site Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis, ALS Functional Ration Scale, TAR-DNA-binding Protein-43, Tamoxifen, mTOR
    View official trial listing →
  • Completed NCT NCT02188745

    ER Reactivation Therapy for Breast Cancer

    Not yet reported Dartmouth-Hitchcock Medical Center 20 participants Est. completion 2024-07-05 3 sites Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02197897

    Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

    Not yet reported Baylor College of Medicine 15 participants Est. completion 2019-06-28 2 sites Stand-alone
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT02206984

    Endocrine Response in Women With Invasive Lobular Breast Cancer

    Not yet reported Priscilla McAuliffe 201 participants Est. completion 2024-07-19 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02269670

    Phase II Study of Everolimus Beyond Progression

    Not yet reported Emory University 3 participants Est. completion 2021-01-25 3 sites Stand-alone
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT02271282

    Estradiol-Receptor Blockade in Older Men and Women

    Not yet reported Mayo Clinic 40 participants Est. completion 2016-05 1 site
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02278120

    Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 672 participants Est. completion 2023-04-20 183 sites Stand-alone
    Other conditions: Advanced Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02285179

    Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen

    Not yet reported, Not yet reported The Netherlands Cancer Institute 189 participants Est. completion 2022-05-01 14 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02291913

    Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 48 participants Est. completion 2019-01-31 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02311647

    Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients

    Sheba Medical Center 120 participants Est. completion 2017-02 1 site
    Other conditions: Endometrial Receptivity Post Tamoxifen Exposure
    View official trial listing →
  • Status unknown NCT NCT02313051

    Everolimus trIal for Advanced prememopausaL Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 200 participants Est. completion 2017-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02333370

    A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 88 participants Est. completion 2022-09-29 15 sites Stand-alone
    Other conditions: Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT02344550

    Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

    Not yet reported Asan Medical Center 137 participants Est. completion 2018-10 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02344940

    Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer

    Not yet reported Shanghai Jiao Tong University School of Medicine 104 participants Est. completion 2018-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02353429

    Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 25 participants Est. completion 2015-12 1 site
    Other conditions: Desmoid Type-fibromatosis
    View official trial listing →
  • Completed NCT NCT02354001

    Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

    Not yet reported The Alfred 80 participants Est. completion 2019-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Status unknown NCT NCT02355600

    Oocyte Recovery During Tamoxifen Adjuvant Therapy

    Instituto de Investigacion Sanitaria La Fe 20 participants Est. completion 2020-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02366130

    Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 45 participants Est. completion 2020-12-16 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02382094

    Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy

    Not yet reported Karolinska University Hospital 110 participants Est. completion 2012-07 Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02384239

    A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer

    Not yet reported University of California, San Francisco 70 participants Est. completion 2021-01-31 9 sites Stand-alone
    Other conditions: Metastatic Breast Cancer, Hormone Receptor Positive
    View official trial listing →
  • Terminated NCT NCT02395627

    Reversing Therapy Resistance With Epigenetic-Immune Modification

    Not yet reported University of California, San Francisco 38 participants Est. completion 2019-06-08 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02404844

    Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer

    Not yet reported University Hospital, Essen 48 participants Est. completion 2017-10-19 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02479256

    Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs

    Not yet reported Ain Shams University 600 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: PCOS
    View official trial listing →
  • Completed NCT NCT02480218

    Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women

    Sunnybrook Health Sciences Centre 47 participants Est. completion 2017-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02488603

    Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

    Not yet reported National Cancer Center, Korea 360 participants Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02506790

    Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

    Not yet reported N.N. Petrov National Medical Research Center of Oncology 96 participants Est. completion 2022-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02513329

    Stellate Ganglion Block (SGB) For Women for Breast Cancer

    Not yet reported Northwestern University 37 participants Est. completion 2020-01 1 site
    Other conditions: Hot Flushes, Hot Flashes
    View official trial listing →
  • Status unknown NCT NCT02513849

    Tamoxifen in Patients With Oesophageal Cancer

    Not yet reported University of Nottingham 20 participants Est. completion 2018-11 2 sites Stand-alone
    Other conditions: Cancer, Gastrointestinal Neoplasms
    View official trial listing →
  • Completed NCT NCT02517593

    Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

    Not yet reported, Not yet reported Mayo Clinic 151 participants Est. completion 2019-12-01 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02584465

    REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression

    Not yet reported ARCAGY/ GINECO GROUP 68 participants Est. completion 2021-09-19 21 sites
    Other conditions: Ovarian Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT02603679

    Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

    Not yet reported Thomas Hatschek 181 participants Est. completion 2031-12-31 3 sites Stand-alone
    Other conditions: Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT02630693

    Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

    Not yet reported Canadian Cancer Trials Group 180 participants Est. completion 2023-11-29 22 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02654093

    A Drug-drug Interaction Study of DP-R213

    Not yet reported Alvogen Korea 24 participants Est. completion 2016-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02668666

    Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

    Not yet reported Oana Danciu, MD 49 participants Est. completion 2023-10-24 7 sites Stand-alone
    Other conditions: Hormone Receptor Positive Malignant Neoplasm of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02690870

    Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 210 participants Est. completion 2019-03 Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02753686

    Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy

    Novartis Pharmaceuticals 440 participants Est. completion 2022-12-01 25 sites
    Other conditions: HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT02762643

    DP-R213 Pharmacokinetics Study

    Not yet reported Alvogen Korea 61 participants Est. completion 2016-08
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT02764541

    Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

    Not yet reported Dana-Farber Cancer Institute 195 participants Est. completion 2031-04 11 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02788201

    Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma

    Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2019-10-23 1 site Stand-alone
    Other conditions: Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02801786

    TAmoxifen Versus LIdocaine Cream. A Randomized Clinical Trial for Reducing Pain and Discomfort During Mammography

    Not yet reported, Not yet reported Universidade Federal de Goias 450 participants Est. completion 2021-06 1 site Stand-alone
    Other conditions: Pain, Discomfort
    View official trial listing →
  • Completed NCT NCT02806544

    Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country

    Not yet reported Vanderbilt University 35 participants Est. completion 2014-09 Stand-alone
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT02819921

    Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

    Not yet reported Seoul National University Hospital 59 participants Est. completion 2019-06-15 3 sites
    Other conditions: Hot Flashes, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02824224

    Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

    Not yet reported Oregon Health and Science University 42 participants Est. completion 2018-01-08 1 site Stand-alone
    Other conditions: Menorrhagia, Metrorrhagia, Medicated Intrauterine Devices
    View official trial listing →
  • Completed NCT NCT02835079

    Treatment Effect of Tamoxifen on Patients With DMD

    Not yet reported Hadassah Medical Organization 19 participants Est. completion 2020-11
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT02866955

    Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.

    Not yet reported Institut de Cancérologie de Lorraine 100 participants Est. completion 2015-08-28 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02903121

    Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users

    Not yet reported Oregon Health and Science University 109 participants Est. completion 2019-06-05 1 site Stand-alone
    Other conditions: Bleeding, Implants, Breakthrough Bleeding
    View official trial listing →
  • Status unknown NCT NCT02914158

    Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

    Not yet reported First Affiliated Hospital, Sun Yat-Sen University 680 participants Est. completion 2025-12 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02936206

    Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

    Not yet reported Icahn School of Medicine at Mount Sinai 2 participants Est. completion 2020-05-01 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02970682

    SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer

    Not yet reported Evgen Pharma 60 participants Est. completion 2019-03 10 sites Stand-alone
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Status unknown NCT NCT02977949

    The Effects of Seasonal Changes in Osteoporosis Treatment

    Toshihiko Kono 200 participants Est. completion 2019-12 1 site
    Other conditions: Selective Estrogen Receptor Modulator (SERM)
    View official trial listing →
  • Completed NCT NCT02979301

    Impact of Low-dose Tamoxifen on BPU

    Not yet reported Mayo Clinic 22 participants Est. completion 2018-11-01 1 site Stand-alone
    Other conditions: High Background Uptake on MBI
    View official trial listing →
  • Completed NCT NCT02982083

    Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

    Not yet reported Sara Saeidi Shahri 34 participants Est. completion 2020-09
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02988986

    TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer

    Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2019-03-30 3 sites Stand-alone
    Other conditions: Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02993159

    Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

    Not yet reported Northwestern University 100 participants Est. completion 2022-01-24 6 sites
    Other conditions: Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive
    View official trial listing →
  • Completed NCT NCT02995772

    Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

    Not yet reported Dharmais National Cancer Center Hospital 122 participants Est. completion 2018-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03006003

    Osteoporosis Treatment in Post-menopausal Women

    Not yet reported Taichung Veterans General Hospital 500 participants Est. completion 2021-12 2 sites
    Other conditions: Depressive Syndrome
    View official trial listing →
  • Completed NCT NCT03010267

    DP-R213 Phase 1 Pharmacokinetics Study

    Not yet reported Alvogen Korea 46 participants Est. completion 2017-03-29
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03043820

    Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

    Not yet reported Iris Sommer 110 participants Est. completion 2021-07-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOS
    View official trial listing →
  • Completed NCT NCT03045653

    Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

    Not yet reported Sun Yat-sen University 30 participants Est. completion 2019-02-21 1 site Stand-alone
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Withdrawn NCT NCT03058939

    Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

    Not yet reported University of Chicago Est. completion 2019-06 1 site
    Other conditions: Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III
    View official trial listing →
  • Status unknown NCT NCT03060304

    The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2020-06 Stand-alone
    Other conditions: Endometrium
    View official trial listing →
  • Completed NCT NCT03063619

    Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast

    Not yet reported M.D. Anderson Cancer Center 194 participants Est. completion 2021-10-26 5 sites
    Other conditions: Mammographically Dense Breast
    View official trial listing →
  • Completed NCT NCT03065621

    Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)

    Not yet reported Jules Bordet Institute 100 participants Est. completion 2023-02-01 5 sites Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Withdrawn NCT NCT03081234

    Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer

    Not yet reported Novartis Pharmaceuticals Est. completion 2025-11-17 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03112031

    Treatment With Tamoxifen in Cryptococcal Meningitis

    Not yet reported Oxford University Clinical Research Unit, Vietnam 50 participants Est. completion 2018-07-17 3 sites Stand-alone
    Other conditions: Meningitis Streptococcal, Hiv, Meningitis, Meningoencephalitis
    View official trial listing →
  • Status unknown NCT NCT03137368

    A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP)

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300 participants Est. completion 2023-10-30 1 site
    Other conditions: CYP2D6 Polymorphism
    View official trial listing →
  • Withdrawn NCT NCT03147196

    Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

    Not yet reported Mayo Clinic Est. completion 2022-06
    Other conditions: Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03161353

    Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.

    Not yet reported MedSIR 377 participants Est. completion 2026-11-01 56 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03184090

    Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

    Not yet reported MedSIR 33 participants Est. completion 2020-10-27 15 sites Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03199963

    Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

    Not yet reported BHR Pharma, LLC 223 participants Est. completion 2019-04-23 19 sites Stand-alone
    Other conditions: Mammographic Breast Density
    View official trial listing →
  • Completed NCT NCT03219476

    Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

    Not yet reported Medical College of Wisconsin 37 participants Est. completion 2025-03-20 1 site Stand-alone
    Other conditions: Breast Cancer, Invasive Breast Cancer
    View official trial listing →
  • Completed NCT NCT03229499

    Pulmonary Hypertension and Anastrozole Trial

    Not yet reported University of Pennsylvania 84 participants Est. completion 2022-07-22 7 sites Stand-alone
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT03272477

    Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

    Not yet reported Palleos Healthcare GmbH 257 participants Est. completion 2024-03-04 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03280563

    A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 144 participants Est. completion 2024-09-26 22 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03354039

    Tamoxifen in Duchenne Muscular Dystrophy

    Not yet reported University Hospital, Basel, Switzerland 93 participants Est. completion 2022-10-18 11 sites Stand-alone
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT03355157

    A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).

    Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2024-08-30 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03381963

    Hemostatic Profiles of Endocrine Therapies for Breast Cancer

    University Hospital, Geneva 100 participants Est. completion 2020-02-28 1 site
    Other conditions: Breast Neoplasms, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT03382834

    Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 31 participants Est. completion 2023-07-27 15 sites Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT03418831

    Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

    Not yet reported Shanghai Mental Health Center 45 participants Est. completion 2019-07-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT03423199

    PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY

    Not yet reported National Cancer Center, Japan 180 participants Est. completion 2025-09 23 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT03493854

    A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

    Not yet reported Hoffmann-La Roche 500 participants Est. completion 2023-06-02 107 sites Stand-alone
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03504631

    Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

    Trisakti University 117 participants Est. completion 2018-12-01 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT03528902

    Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension

    Not yet reported Vanderbilt University Medical Center 18 participants Est. completion 2023-06-14 1 site Stand-alone
    Other conditions: Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension, Primary Pulmonary Hypertension, Lung Diseases, Tamoxifen, Estrogen Receptor Antagonist, Hormone Antagonists, Estrogens
    View official trial listing →
  • Active, not recruiting NCT NCT03573648

    Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2027-03-30 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03582865

    Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

    Assiut University 100 participants Est. completion 2020-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03623633

    Comparative Antiresorptive Efficacy Discontinuation of Denosumab

    Not yet reported Massachusetts General Hospital 51 participants Est. completion 2023-08-01 1 site
    Other conditions: Osteoporosis, Postmenopausal, Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT03664895

    Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

    Not yet reported Seoul National University Hospital 224 participants Est. completion 2024-12-31 1 site
    Other conditions: Breast Cancer Invasive
    View official trial listing →
  • Completed NCT NCT03691493

    Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

    Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sites Stand-alone
    Other conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Active, not recruiting NCT NCT03707340

    A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

    Not yet reported Memorial Sloan Kettering Cancer Center 43 participants Est. completion 2027-10-14 7 sites
    Other conditions: Breast Cancer, Hyposexual Desire Disorder
    View official trial listing →
  • Completed NCT NCT03715413

    Analgesic Efficacy of Pulsed Radiofrequency in Non-cyclic Mastalgia

    Not yet reported Mansoura University 64 participants Est. completion 2018-12-01 1 site
    Other conditions: Breast Fibroadenoma
    View official trial listing →
  • Completed NCT NCT03719495

    Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

    Duke University 68 participants Est. completion 2023-07-31 1 site
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, Healthy
    View official trial listing →
  • Completed NCT NCT03764462

    Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers

    Not yet reported Addpharma Inc. 52 participants Est. completion 2019-02-08 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Active, not recruiting NCT NCT03820830

    Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 405 participants Est. completion 2029-01-01 53 sites Stand-alone
    Other conditions: Breast Cancer Recurrent
    View official trial listing →
  • Completed NCT NCT03824171

    Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers

    Not yet reported Addpharma Inc. 52 participants Est. completion 2019-04-08 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT03844685

    Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88 participants Est. completion 2016-02-23 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03870399

    Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

    Not yet reported AC Camargo Cancer Center 23 participants Est. completion 2023-05-13 2 sites Stand-alone
    Other conditions: Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor
    View official trial listing →
  • Active, not recruiting NCT NCT03879577

    Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

    Not yet reported University of Chicago 53 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Breast Cancer, Breast Cancer Female, HER2-positive Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III
    View official trial listing →
  • Completed NCT NCT03898947

    Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies

    Università degli Studi dell'Insubria 1329 participants Est. completion 2019-12
    Other conditions: Breast Cancer, Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT03925233

    Breast Cancer Treatment Based on Organ-like Culture

    Xijing Hospital 300 participants Est. completion 2021-12-15 1 site
    Other conditions: Breast Cancer Organoids
    View official trial listing →
  • Completed NCT NCT03948568

    Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

    Not yet reported Ottawa Hospital Research Institute 262 participants Est. completion 2022-04-09 1 site
    Other conditions: Early-stage Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04009044

    Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

    Not yet reported Northwestern University 156 participants Est. completion 2026-06-25 2 sites
    Other conditions: Cancer Survivor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04023292

    Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 185 participants Est. completion 2025-07 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT04024462

    A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

    Not yet reported Hoffmann-La Roche 200 participants Est. completion 2026-01-19 18 sites Stand-alone
    Other conditions: HER2-positive Early Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04038489

    COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer

    Not yet reported University of Virginia Est. completion 2023-04-30 1 site Stand-alone
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04059484

    Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

    Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT04080297

    Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

    Not yet reported Que Oncology 21 participants Est. completion 2014-07-28
    Other conditions: Vasomotor Symptoms (VMS)
    View official trial listing →
  • Status unknown NCT NCT04116827

    Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device

    Samsung Medical Center 20 participants Est. completion 2020-12-31 1 site
    Other conditions: Sleep Disorder, Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04134598

    ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer

    Not yet reported Azienda Ospedaliero-Universitaria Careggi 926 participants Est. completion 2030-03-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04246606

    Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer

    UNICANCER 155 participants Est. completion 2023-11-01 1 site
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Active, not recruiting NCT NCT04272801

    Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer

    Not yet reported Shayna Showalter, MD 84 participants Est. completion 2026-06-01 2 sites Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT04300790

    Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

    Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04383275

    Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)

    Not yet reported Fudan University 367 participants Est. completion 2031-07-06 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04389424

    Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer

    Instituto Jalisciense de Cancerologia 300 participants Est. completion 2022-01-30 1 site
    Other conditions: Breast Cancer, Endocrine Therapy, Endocrine Therapy Adverse Reaction, Vitamin D Deficiency, Nutrition Disorders, Obesity
    View official trial listing →
  • Status unknown NCT NCT04389580

    Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus

    Not yet reported Kafrelsheikh University 160 participants Est. completion 2021-12
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04433494

    A Study of TY-302 in Patients With Advanced Solid Tumors

    Not yet reported TYK Medicines, Inc 60 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Breast Cancer, Solid Tumor
    View official trial listing →
  • Terminated NCT NCT04460430

    Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer

    Not yet reported SOLTI Breast Cancer Research Group 12 participants Est. completion 2021-11-29 15 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04479098

    Effects of Training and Detraining on Postmenopausal Breast Cancer Survivors

    Not yet reported Federal University of Uberlandia 14 participants Est. completion 2018-06-30 1 site Stand-alone
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Status unknown NCT NCT04488107

    Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

    Not yet reported, Not yet reported Ahon Pharmaceutical Co., Ltd. 78 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Enrolling by invitation NCT NCT04488614

    Prospective Breast Cancer Biobanking

    Helse Stavanger HF 1200 participants Est. completion 2030-07-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04504331

    Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

    Not yet reported Jennifer Lee Caswell-Jin 4 participants Est. completion 2021-10-22 1 site Stand-alone
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04531748

    Selective Estrogen Modulation and Melatonin in Early COVID-19

    Not yet reported Reena Mehra, MD Est. completion 2022-09
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04568096

    Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19

    Not yet reported Kafrelsheikh University 160 participants Est. completion 2020-12
    Other conditions: the Lung Complication of COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT04569747

    A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 393 participants Est. completion 2032-09-01 32 sites
    Other conditions: HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer, Node Negative Breast Cancer, Micrometastasis Breast Cancer, Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04570956

    Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

    Not yet reported Mayo Clinic 65 participants Est. completion 2024-10-15 3 sites Stand-alone
    Other conditions: Breast Atypical Hyperplasia, Breast Lobular Carcinoma in Situ, Breast Atypical Lobular Hyperplasia, Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04666805

    Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

    First Hospital of China Medical University 1354 participants Est. completion 2021-01-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04733118

    Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer

    Not yet reported MedSIR 393 participants Est. completion 2028-03 41 sites Stand-alone
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT04736693

    Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data

    Brigham and Women's Hospital 18028 participants Est. completion 2021-02-18 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Status unknown NCT NCT04891731

    Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120 participants Est. completion 2023-09
    Other conditions: Hormone Receptor-positive Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04906395

    Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

    Not yet reported Tolmar Inc. 250 participants Est. completion 2027-01-30 59 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04926545

    XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

    Not yet reported Guangzhou University of Traditional Chinese Medicine 24 participants Est. completion 2024-07-20 1 site
    Other conditions: Malignant Tumor, Diarrhea
    View official trial listing →
  • Withdrawn NCT NCT04933240

    Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial

    Not yet reported Virginia Commonwealth University Est. completion 2024-12 2 sites
    Other conditions: Vaginal Bleeding
    View official trial listing →
  • Status unknown NCT NCT04961632

    Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

    Not yet reported National Cancer Centre, Singapore 75 participants Est. completion 2025-11 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04961996

    A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 4170 participants Est. completion 2033-09-30 621 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04995731

    Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer

    Assiut University 328 participants Est. completion 2024-07 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT05016349

    Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

    Not yet reported Mahmoud Ramadan mohamed Elkazzaz 160 participants Est. completion 2021-12 Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT05026073

    Vibrational Spectroscopy for Endometrial Cancer Diagnosis

    Nottingham University Hospitals NHS Trust 150 participants Est. completion 2024-11 1 site
    Other conditions: Endometrial Cancer, Endometrial Hyperplasia
    View official trial listing →
  • Completed NCT NCT05101564

    Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer

    Not yet reported Jennifer Lee Caswell-Jin 19 participants Est. completion 2024-06-03 1 site Stand-alone
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT05110170

    Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

    Not yet reported Luye Pharma Group Ltd. 188 participants Est. completion 2022-06-24 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05131893

    Neoadjuvant Treatment of Breast Cancer

    National Institute of Oncology, Hungary 300 participants Est. completion 2031-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05133674

    Therapeutic Dose Monitoring (TDM) of Tamoxifen

    Not yet reported Karolinska University Hospital 40 participants Est. completion 2023-03-01 1 site Stand-alone
    Other conditions: Breast Cancer, Breast Carcinoma, Breast Tumors, Cancer of Breast, Malignant Neoplasm of Breast
    View official trial listing →
  • Completed NCT NCT05156892

    Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer

    Not yet reported Anthony Joshua, FRACP 12 participants Est. completion 2026-11-01 1 site Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Status unknown NCT NCT05157373

    The Effect of Androgen Receptor Polymorphism on Endometrial Cancer

    University of Nicosia 150 participants Est. completion 2024-04-01
    Other conditions: Androgen Receptor Abnormal, Endometrial Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT05161195

    Roll-over Study to Allow Continued Access to Ribociclib

    Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2030-08-14 73 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT05172050

    Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

    Not yet reported, Not yet reported Dompé Farmaceutici S.p.A 61 participants Est. completion 2021-06-12 11 sites
    Other conditions: SARS CoV 2 Infection
    View official trial listing →
  • Status unknown NCT NCT05200663

    Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility

    Not yet reported Sharif Medical Research Center 110 participants Est. completion 2022-10 1 site Stand-alone
    Other conditions: Oligoasthenoteratozoospermia, Male Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT05296798

    A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 922 participants Est. completion 2030-12-31 198 sites Stand-alone
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05306340

    A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

    Not yet reported Genentech, Inc. 373 participants Est. completion 2027-06-15 136 sites
    Other conditions: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05460819

    Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

    Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-07-31 1 site
    Other conditions: Hot Flashes, Breast Cancer, Acupuncture
    View official trial listing →
  • Active, not recruiting NCT NCT05463601

    Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 132 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05501158

    CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population

    Not yet reported Nalagenetics Pte Ltd 150 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05524116

    Telehealth Exercise and Mindfulness for Pain in Osteoarthritis

    Not yet reported Boston University Charles River Campus 45 participants Est. completion 2023-07-03 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Status unknown NCT NCT05525481

    Tamoxifen Prediction Study in Patients With ER+ Breast Cancer

    Not yet reported Erasmus Medical Center 100 participants Est. completion 2024-02-28 1 site Stand-alone
    Other conditions: ER+ Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05613504

    Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

    Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-12-01 1 site
    Other conditions: Hot Flashes, Breast Cancer, Acupuncture
    View official trial listing →
  • Enrolling by invitation NCT NCT05645536

    Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

    Not yet reported Tolmar Inc. 250 participants Est. completion 2030-03 46 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05659563

    Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%

    Not yet reported MedSIR 92 participants Est. completion 2025-01-30 18 sites
    Other conditions: Breast Cancer, Breast Cancer, Early-Onset
    View official trial listing →
  • Active, not recruiting NCT NCT05780567

    Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 1946 participants Est. completion 2027-01 3 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05800197

    Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

    Blokhin's Russian Cancer Research Center 300 participants Est. completion 2025-01-15 1 site
    Other conditions: Breast Cancer, Neoadjuvant Endocrine Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT05826964

    Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

    Not yet reported University of Miami 24 participants Est. completion 2030-11-30 1 site Stand-alone
    Other conditions: Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05861830

    Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)

    Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05870813

    CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer

    Institut fuer Frauengesundheit 3000 participants Est. completion 2023-12 1 site
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05889871

    A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer

    Not yet reported Fudan University 916 participants Est. completion 2026-06-01 Stand-alone
    Other conditions: HR+/HER2-breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05890287

    A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-10-01 1 site Stand-alone
    Other conditions: HR Positive HER2 Negative Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT05908773

    A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors

    Not yet reported TransCode Therapeutics 1 participants Est. completion 2023-09-18 1 site
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Active, not recruiting NCT NCT06001762

    TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 90 participants Est. completion 2027-01-01 12 sites Stand-alone
    Other conditions: Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT06033092

    Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

    Not yet reported European Institute of Oncology 110 participants Est. completion 2026-07-31 4 sites
    Other conditions: BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ, Lobular Carcinoma in Situ, ATM Gene Mutation, CHEK2 Gene Mutation, CDH1 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
    View official trial listing →
  • Status unknown NCT NCT06120595

    Intervention Study Based on Real-world Data to Improve Quality of Life After Breast Cancer Treatment, the REBECCA-2 Study

    Not yet reported Helse Stavanger HF 81 participants Est. completion 2025-05-01 1 site Stand-alone
    Other conditions: Cancer Related Fatigue
    View official trial listing →
  • Status unknown NCT NCT06154590

    Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

    DR. DIANE CHISESI NFS. MD. PHD. 100 participants Est. completion 2026-09 1 site
    Other conditions: Metastatic Breast Cancer, Tumor, Muscle Neoplasms, Chronic Pain
    View official trial listing →
  • Not yet recruiting NCT NCT06223698

    Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer

    Not yet reported Region Örebro County 3832 participants Est. completion 2035-05-02 15 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06346457

    Breast Cancer & Antiestrogenic Therapy & Brain

    International Research Training Group 2804 180 participants Est. completion 2026-04-01 1 site
    Other conditions: Breast Cancer Female, Healthy Female, Menopause, Anti-estrogenic Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT06355401

    Maintenance Hormonal Therapy and DLBCL

    Not yet reported, Not yet reported Sohag University 100 participants Est. completion 2029-03 Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06404775

    External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 456 participants Est. completion 2030-05-16 1 site Stand-alone
    Other conditions: Mastalgia
    View official trial listing →
  • Active, not recruiting NCT NCT06440967

    A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

    Not yet reported Astellas Pharma Global Development, Inc. 982 participants Est. completion 2028-04-30 110 sites Stand-alone
    Other conditions: Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT06449027

    Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 211 participants Est. completion 2026-03 1 site Stand-alone
    Other conditions: Breast Cancer Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT06492616

    A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

    Not yet reported Stemline Therapeutics, Inc. 4556 participants Est. completion 2032-10 555 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06580535

    Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas

    Assiut University 100 participants Est. completion 2025-12
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Terminated NCT NCT06630325

    A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

    Not yet reported OHSU Knight Cancer Institute 6 participants Est. completion 2026-03-11 1 site Stand-alone
    Other conditions: Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Carcinoma, Advanced Sarcoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8
    View official trial listing →
  • Terminated NCT NCT06660030

    Factors Influencing Tamoxifen Adherence in Women With Breast Cancer Receiving Tamoxifen in Botswana.

    University of Pennsylvania 10 participants Est. completion 2025-11-20 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Suspended NCT NCT06671912

    Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

    Not yet reported Alliance for Clinical Trials in Oncology 1556 participants Est. completion 2031-11-30 732 sites Stand-alone
    Other conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ
    View official trial listing →
  • Active, not recruiting NCT NCT06684587

    Telehealth Exercise and Mindfulness for Pain in Osteoarthritis - Stage 1B

    Not yet reported Boston University Charles River Campus 66 participants Est. completion 2027-08 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT06840847

    Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormone Agonists (LHRHa )

    Not yet reported Canan Kas 79 participants Est. completion 2024-10-29 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT06982313

    Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms

    Ente Ospedaliero Ospedali Galliera 1545 participants Est. completion 2026-03-08 2 sites
    Other conditions: Breast Cancer Invasive
    View official trial listing →
  • Completed NCT NCT07072013

    An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer

    Novartis Pharmaceuticals 1937 participants Est. completion 2025-04-24 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07101159

    Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

    Not yet reported Fujian Cancer Hospital 200 participants Est. completion 2031-12 Stand-alone
    Other conditions: Early Breast Cancer, Adjuvant Therapy, Hormone Receptor Positive / HER2-negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07153757

    De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial

    Not yet reported Fudan University 2934 participants Est. completion 2033-09-01 1 site Stand-alone
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Not yet recruiting NCT NCT07213206

    CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer

    Not yet reported Fudan University 1500 participants Est. completion 2035-09-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07447024

    Selected Exercise Program on Upper Cross Syndrome Post-unilateral Mastectomy

    Not yet reported Cairo University 60 participants Est. completion 2026-06-15 1 site Stand-alone
    Other conditions: Mastectomy
    View official trial listing →
  • Not yet recruiting NCT NCT07499999

    Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 140 participants Est. completion 2028-08-31 2 sites Stand-alone
    Other conditions: Breast Cancer, Ductal Carcinoma, Estrogen-receptor-positive Breast Cancer, Atypical Lobular Hyperplasia, BRCA2 Mutation, CHEK2 Gene Mutation, Ataxia Telangiectasia Mutated Gene Mutation
    View official trial listing →
  • Not yet recruiting NCT NCT07729046

    Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer

    Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 site
    Other conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07806630

    SHORTened Duration of TAMoxifen

    Not yet reported Rutgers, The State University of New Jersey 250 participants Est. completion 2029-07 1 site Stand-alone
    Other conditions: High Risk for Invasive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07844759

    SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers

    Not yet reported Renaissance Institute of Precision Oncology and Radiosurgery 30 participants Est. completion 2032-01-01 1 site Stand-alone
    Other conditions: Breast Cancer, Early-Stage Breast Carcinoma, Hormone Receptor-Positive Breast Cancer, HER2-Negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07859319

    Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting

    Not yet reported Hospices Civils de Lyon 105 participants Est. completion 2028-03 3 sites Stand-alone
    Other conditions: Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management, Adjuvant Treatment, Patient Acceptability, Joint Pain
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Tamoxifen Citrate, Tamoxifen, TMX

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.